Saturday, October 3, 2026

Silver Futures Is 5% Up In The Last 10 Sessions

ViaNews Editorial Team

November 26, 2023

Silver Futures Is 5% Up In The Last 10 Sessions

(VIANEWS) - Silver (SI) has been up by 5.19% for the last 10 sessions. At 01:50 EST on Sunday, 26 November, Silver (SI) is $24.34.

Volume

Today's last reported volume for Silver is 64721, 99.99% below its average volume of 11273369623.64.

Volatility

Silver's last week, last month's, and last quarter's current intraday variation average was a negative 0.22%, a positive 0.54%, and a positive 1.22%, respectively.

Silver's highest amplitude of average volatility was 0.82% (last week), 1.27% (last month), and 1.22% (last quarter), respectively.

Previous days news about Silver (SI)

  • Silver sees late jump on Friday, touches 12-week high at $24.30. According to FXStreet on Friday, 24 November, "Friday's late bump in the XAG/USD sees Spot Silver trading into overall positive territory for the year since declining from September's peak at $25.00.", "Should bearish price momentum return to the fold, a downside break of $23.50 will harden the descending trendline and set up Silver bears for a fresh run at the last swing low into the $22.00 handle."

News about

  • Crude oil forecast: quiet during holiday session - 24 November 2023. According to DailyForex on Friday, 24 November, "Looking to the West Texas Intermediate (WTI) Crude Oil market, we saw a slight downturn during Thursday's trading session, characterized by the persistently erratic behavior witnessed across global markets. "

More news about Silver (SI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com